Current status of trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties.
Lin
J T
JT
Bertino
J R
JR
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000494:pharmacology*; D004341:Drug Evaluation; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D011799:Quinazolines / Q000009:adverse effects / Q000494:pharmacology*; D016597:Trimetrexate
D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D005493:Folic Acid Antagonists; D011799:Quinazolines; D016597:Trimetrexate